FREENOME
About
Implement and refine DL pipelines on distributed computing platforms enhancing the speed and efficiency of DL operations including model training, data handling, model management, and inference.
Collaborate closely with ML scientists and software engineers to understand current challenges and requirements and ensure that the DL model development pipelines you create are perfectly aligned with scientific goals and operational needs.
Continuously monitor, evaluate, and optimize DL model train...
Updates & Highlights
Perceptive Capital (PCSC) to merge with Freenome; $240M PIPE, 83M shares
Perceptive Capital (PCSC) to merge with Freenome; $240M PIPE, 83M shares
Stock Titan · 11 days ago
PCSC (PCSC) to file S-4, proxy/prospectus for Freenome merger
PCSC (PCSC) to file S-4, proxy/prospectus for Freenome merger
Stock Titan · 26 days ago
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
PR Newswire · about 2 months ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Freenome?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentPerceptive Capital (PCSC) to merge with Freenome; $240M PIPE, 83M shares
Perceptive Capital (PCSC) to merge with Freenome; $240M PIPE, 83M shares
Stock Titan · 11 days ago
PCSC (PCSC) to file S-4, proxy/prospectus for Freenome merger
PCSC (PCSC) to file S-4, proxy/prospectus for Freenome merger
Stock Titan · 26 days ago
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
PR Newswire · about 2 months ago
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
PR Newswire · 4 months ago
Freenome Goes Public In $330M SPAC, Shares Early Data For Next-Gen CRC Blood Test
Freenome Goes Public In $330M SPAC, Shares Early Data For Next-Gen CRC Blood Test
Citeline News & Insights · 5 months ago
Freenome inks deals to list stock and raise $330M
Freenome inks deals to list stock and raise $330M
MedTech Dive · 5 months ago
Freenome And Perceptive Capital Merging In $330 Million SPAC Deal Backed By $240 Million PIPE
Freenome And Perceptive Capital Merging In $330 Million SPAC Deal Backed By $240 Million PIPE
Pulse 2.0 · 5 months ago
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform
PR Newswire · 5 months ago
Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger
Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger
MedCity News · 5 months ago
Cancer blood test maker Freenome going public with $330M SPAC
Cancer blood test maker Freenome going public with $330M SPAC
BioWorld News · 5 months ago
Cancer blood test developer Freenome to go public in $330M SPAC deal
Cancer blood test developer Freenome to go public in $330M SPAC deal
Fierce Biotech · 5 months ago
Cancer detection firm Freenome to go public via $330 million SPAC deal
Cancer detection firm Freenome to go public via $330 million SPAC deal
statnews.com · 5 months ago
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide
Oncodaily · 5 months ago
Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests
Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests
Fierce Biotech · 6 months ago
Roche inks deal for rights to Freenome cancer tests outside US
Roche inks deal for rights to Freenome cancer tests outside US
BioPharma Dive · 6 months ago
Roche inks deal for rights to Freenome cancer tests outside US
Roche inks deal for rights to Freenome cancer tests outside US
MedTech Dive · 6 months ago
GenomeWeb Best Places to Work Winner, 251+ Employees: Freenome
GenomeWeb Best Places to Work Winner, 251+ Employees: Freenome
GenomeWeb · 6 months ago
Freenome and Roche partner on cancer screening technology for ex-US markets
Freenome and Roche partner on cancer screening technology for ex-US markets
Yahoo Finance · 6 months ago
Freenome teams up with Roche for cancer screening tests
Freenome teams up with Roche for cancer screening tests
MobiHealthNews · 6 months ago
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
PR Newswire · 6 months ago